LGMDD1 natural history and phenotypic spectrum: Implications for clinical trials is a research paper published in Annals of Clinical and Translational Neurology (2022). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: K08AR075894
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: K24AR073317
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: R01AR068797
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: R03AR081395
Washington University in St. Louis
Grant: Faculty Scholar Award ‐ Children's Discovery Insti
FWCI
0.78
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords